Patents by Inventor Deborah A. Schaefer

Deborah A. Schaefer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeted cryptosporidium biocides
    Patent number: 8703134
    Abstract: The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.
    Type: Grant
    Filed: February 6, 2013
    Date of Patent: April 22, 2014
    Assignees: ioGenetics, LLC, Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: Michael Imboden, Michael Riggs, Deborah A. Schaefer, Jane Homan, Robert D. Bremel
  • TARGETED CRYPTOSPORIDIUM BIOCIDES
    Publication number: 20130230516
    Abstract: The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.
    Type: Application
    Filed: February 6, 2013
    Publication date: September 5, 2013
    Applicants: Arizona Board of Regents on behalf of the University of Arizona, ioGenetics, LLC
    Inventors: Michael Imboden, Michael Riggs, Deborah A. Schaefer, Jane Homan, Robert D. Bremel
  • Targeted cryptosporidium biocides
    Patent number: 8394379
    Abstract: The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: March 12, 2013
    Assignee: ioGenetics, LLC
    Inventors: Michael Imboden, Michael Warren Riggs, Deborah A. Schaefer, Jane Homan
  • TARGETED CRYPTOSPORIDIUM BIOCIDES
    Publication number: 20100183611
    Abstract: The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.
    Type: Application
    Filed: January 13, 2010
    Publication date: July 22, 2010
    Applicants: IOGENETICS, LLC., ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Michael Imboden, Michael Riggs, Deborah A. Schaefer, Jane Homan
  • TARGETED BIOCIDES
    Publication number: 20100034824
    Abstract: The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule (e.g., immunoglobulin or innate immune system receptor molecule) and a biocide (e.g., bactericidal enzyme) in transgenic animals (e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., beef carcass processing).
    Type: Application
    Filed: August 5, 2009
    Publication date: February 11, 2010
    Applicants: IOGENETICS, LLC, THE ARIZONA BOARD OF REGENTS
    Inventors: Michael Imboden, Michael Riggs, Deborah A. Schaefer
  • Biocides
    Patent number: 7566447
    Abstract: The present invention relates to the use of biocide (e.g., bactericidal enzyme) to target pathogens. In particular, the present invention provides biocides for use in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., water purification).
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: July 28, 2009
    Assignees: Iogenetics, LLC, The Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: Jane Homan, Michael Imboden, Michael Riggs, Stephane Carryn, Deborah A. Schaefer
  • Targeted biocides
    Publication number: 20070104722
    Abstract: The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule (e.g., immunoglobulin or innate immune system receptor molecule) and a biocide (e.g., bactericidal enzyme) in transgenic animals (e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., beef carcass processing).
    Type: Application
    Filed: October 10, 2006
    Publication date: May 10, 2007
    Applicants: ioGenetics, University of Arizona
    Inventors: Michael Imboden, Michael Riggs, Deborah Schaefer
  • Biocides
    Publication number: 20060147442
    Abstract: The present invention relates to the use of biocide (e.g., bactericidal enzyme) to target pathogens. In particular, the present invention provides biocides for use in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., water purification).
    Type: Application
    Filed: October 20, 2005
    Publication date: July 6, 2006
    Applicants: ioGenetics, University of Arizona
    Inventors: Jane Homan, Michael Imboden, Michael Riggs, Stephane Carryn, Deborah Schaefer